Trial Details

COMPLETED
Basic Information
Clinical ID c1323
Identifier NCT02463045
Trial Title Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: TOP1288
Participant Information
Sponsor Topivert Pharma Ltd
City London
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-05-15
Primary Completion Date 2025-07-16
Completion Date 2025-07-16